(Q34071570)

30 July 2017

1 reference

title

Risk factors assessment in fabrile neutropenia (English)

1 reference

30 July 2017

Paesmans M

1

1 reference

30 July 2017

1 October 2000

1 reference

International Journal of Antimicrobial Agents

30 July 2017

1 reference

30 July 2017

16

1 reference

30 July 2017

2

1 reference

30 July 2017

107-111

1 reference

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Is it time to redefine the management of febrile neutropenia in cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Fever and neutropenia--how to use a new treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Approach to treatment of the febrile cancer patient with low-risk neutropenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Infection risk factors in febrile, neutropenic children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Predicting the risk of bacteremia in childen with fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

What price perfection? Calibration and discrimination of clinical prediction models

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Assessing the generalizability of prognostic information

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900213-2

7 January 2021

10.1016/S0924-8579(00)00213-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11053789